Skip to content

My Pharmacy News

mypharmacynews.com

  • Health News
  • Medications
  • Health Problems
  • Beauty & Balance
  • Personal Health

Home ยป HER2

05/01/2019

HER2 positive breast cancer: Treatment de-escalation needs to be personalized

De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be personalised, according to Dr. Carmen

Continue reading »
07/10/2018

Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer

Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1

Continue reading »
05/18/2018

Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months

Continue reading »
Latest Posts
Assisted reproductive technology not tied to higher BMI in childhood, finds study
What’s the difference between physical and chemical sunscreens? And which one should you choose?
How medical manufacturing trends are evolving: From performance testing to 3D vision
Health Problems
What are Drug-Induced Nail Disorders?
Current State of Clinical Diagnostics
Machine Learning for Targeted Disease Treatment
Recent Posts
  • Assisted reproductive technology not tied to higher BMI in childhood, finds study
  • What’s the difference between physical and chemical sunscreens? And which one should you choose?
  • How medical manufacturing trends are evolving: From performance testing to 3D vision
  • New tool assesses role of ’embeddedness’ in learning health systems
  • NHS strike chaos begins as A&E unit CLOSES ahead of three-day walk-out
Copyright © 2024
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok